FDA-Selected Kidney Disease Devices Still In Early Development
This article was originally published in The Gray Sheet
Executive Summary
Investigational devices from CreatiVasc Medical, Blood Purification Technologies and the University of California, San Francisco were selected for CDRH’s “innovation pathway 2.0” program.